Alexa Stephan

Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies

Aaron Burmeister, Alexa Stephan, Leandro A. Alves Avelar et al. · Molecular Cancer Therapeutics · 2022 · 25 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights

Melanie Müller, Aaron Burmeister, Margaretha A. Skowron et al. · Clinical Epigenetics · 2022 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +15

Profiling the <scp>3D</scp> interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level

Margaretha A. Skowron, Katharina Eul, Alexa Stephan et al. · Molecular Oncology · 2022 · 22 citations · Full text

Medicine, Cell Biology, Oncology +17

Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers

Pailin Pongratanakul, Felix Bremmer, Stella Pauls et al. · Cancer Letters · 2024 · 13 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Induction of <scp>SOX17</scp> with stimulation of <scp>WNT</scp>, <scp>TGF</scp>‐beta, and <scp>FGF</scp> signaling drives embryonal carcinomas into the yolk‐sac tumor lineage resulting in increased cisplatin resistance

Mara Kotthoff, Margaretha A. Skowron, Felix Bremmer et al. · International Journal of Cancer · 2025 · 11 citations · Full text

Medicine, Developmental Biology, Oncology +17